Health Populi
DECEMBER 22, 2022
Entering 2023, U.S. health citizens face physical, financial, and mental health challenges of a syndemic, inflation, and stress – all of which will shape peoples’ demand side for health care and digital technology, and a supply side of providers challenged by tech-enabled organizations with design and data chops.
Health Populi
DECEMBER 19, 2022
For over ten years, digital health technology has been a fast-growing area at the annual CES , the largest convention covering consumer electronics in the world. Gary’s Book Club featured my HealthConsuming: From Health Consumer to Health Citizen at the 2020 CES. At CES 2023, sleep is a major segment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
OCTOBER 23, 2023
CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. EST) on November 8, 2023 (the “Special Meeting”). on June 30, 2023. Nassau, Bahamas, at 9 a.m.
Lloyd Price
NOVEMBER 25, 2023
Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.
Lloyd Price
SEPTEMBER 2, 2023
Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.
Digital Health Global
JANUARY 11, 2024
Following Frontiers Health 2023, I had the privilege of sitting down with Dominick Kennerson to delve deeper into the mission of HSBC Innovation Banking and the future trends shaping health. Can you tell us a bit more about what HSBC Innovation Banking is, and what the organisation is aiming to bring to the health tech space?
Digital Health Global
JANUARY 9, 2024
Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably. Since 2017, Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.
Expert insights. Personalized for you.
156 
Let's personalize your content